Effects of Nonalbuminuric Type 2 Diabetes Mellitus on Renal Outcomes

被引：0
|
作者：
Choi, Dughyun
Park, Samel
Lee, Eun Young
机构：
来源：
DIABETES | 2024年 / 73卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
10.2337/db24-420-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
420-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effects of Xylooligosaccharides in Type 2 Diabetes Mellitus
    Sheu, Wayne Huey-Herng
    Lee, I-Te
    Chen, Wei
    Chan, Yin-Ching
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2008, 54 (05) : 396 - 401
  • [22] Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA
    McGuire, Darren K.
    Alexander, John H.
    Johansen, Odd Erik
    Perkovic, Vlado
    Rosenstock, Julio
    Cooper, Mark E.
    Wanner, Christoph
    Kahn, Steven E.
    Toto, Robert D.
    Zinman, Bernard
    Baanstra, David
    Pfarr, Egon
    Schnaidt, Sven
    Meinicke, Thomas
    George, Jyothis T.
    von Eynatten, Maximilian
    Marx, Nikolaus
    Aizenberg, D.
    Fiorella, A.
    Edgardo, N.
    Belen, C. Ianina
    Alonso, P.
    Walter, M.
    Maia, K.
    Guillermo, S.
    Leandro, B.
    Constanza, R. M.
    Alejandra, N. M.
    Melina, C.
    Ariel, I. L.
    Martin, S.
    Rodrigo, C.
    Alvarez, C.
    Jorge, M. Z.
    Gabriel, C.
    German, S.
    Bartolacci, I.
    Bolobanich, G. A.
    Tale, T.
    Meritano, M.
    Echeverria, M. G.
    Gerrini, S. P.
    Alvarez, M. R. y
    Torrijos, N.
    Berli, M.
    Coggiola, J.
    Castaneda, G.
    Rode, R.
    Milessi, R.
    Roude, A.
    CIRCULATION, 2019, 139 (03) : 351 - 361
  • [23] Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial
    Oyama, Kazuma
    Raz, Itamar
    Cahn, Avivit
    Kuder, Julia
    Murphy, Sabina A.
    Bhatt, Deepak L.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Wilding, John P. H.
    Park, Kyong-Soo
    Goudev, Assen
    Diaz, Rafael
    Spinar, Jindrich
    Gause-Nilsson, Ingrid A. M.
    Mosenzon, Ofri
    Sabatine, Marc S.
    Wiviott, Stephen D.
    EUROPEAN HEART JOURNAL, 2022, 43 (31) : 2958 - 2967
  • [24] Effects of a medication assistance program on health outcomes in patients with type 2 diabetes mellitus
    Strum, MW
    Hopkins, R
    West, DS
    Harris, BN
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (10) : 1048 - 1052
  • [25] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12): : 861 - 869
  • [26] Renal affection in hypertensive patients with type 2 diabetes mellitus
    Makolkin, V. I.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (01) : 74 - 77
  • [27] Peculiarities of renal affection in patients with type 2 diabetes mellitus
    Savelieva, S. A.
    Kozlovskaya, N. L.
    Bobkov, I. N.
    Varshavsky, V. A.
    Golitsina, E. P.
    DIABETES MELLITUS, 2009, 12 (04): : 114 - 116
  • [28] THE HETEROGENEITY OF RENAL DAMAGE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Tomilina, Natalia
    Zhilinskaya, Tatiana
    Stolyarevich, Ekaterina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 431 - 431
  • [29] Pathomechanism of Renal Damage in Type 2 Diabetes Mellitus Patients
    Sambara, Yuliana
    Arief, Mansyur
    Bahrun, Uleng
    INDONESIAN BIOMEDICAL JOURNAL, 2013, 5 (03): : 161 - 168
  • [30] Pathology and Prognosis of Type 2 Diabetes Mellitus with Renal Involvement
    Cheng, Lu
    Fu, Ping
    CHINESE MEDICAL JOURNAL, 2017, 130 (08) : 883 - 884
12345